- Home
- ATNF vs BDRX Comparison
ATNF vs BDRX Comparison
Compare ATNF & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- BDRX
- Stock Information
- Founded
- ATNF 2016
- BDRX 2000
- Country
- ATNF United States
- BDRX United Kingdom
- Employees
- ATNF N/A
- BDRX N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- ATNF Health Care
- BDRX Health Care
- Exchange
- ATNF Nasdaq
- BDRX Nasdaq
- Market Cap
- ATNF 3.8M
- BDRX 3.6M
- IPO Year
- ATNF N/A
- BDRX N/A
- Fundamental
- Price
- ATNF $1.05
- BDRX $1.15
- Analyst Decision
- ATNF
- BDRX
- Analyst Count
- ATNF 0
- BDRX 0
- Target Price
- ATNF N/A
- BDRX N/A
- AVG Volume (30 Days)
- ATNF 43.3K
- BDRX 3.6M
- Earning Date
- ATNF 05-15-2025
- BDRX 04-11-2025
- Dividend Yield
- ATNF N/A
- BDRX N/A
- EPS Growth
- ATNF N/A
- BDRX N/A
- EPS
- ATNF N/A
- BDRX N/A
- Revenue
- ATNF N/A
- BDRX N/A
- Revenue This Year
- ATNF N/A
- BDRX N/A
- Revenue Next Year
- ATNF N/A
- BDRX N/A
- P/E Ratio
- ATNF N/A
- BDRX N/A
- Revenue Growth
- ATNF N/A
- BDRX N/A
- 52 Week Low
- ATNF $0.66
- BDRX $1.01
- 52 Week High
- ATNF $17.75
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- ATNF 49.77
- BDRX 39.66
- Support Level
- ATNF $1.01
- BDRX $1.01
- Resistance Level
- ATNF $1.10
- BDRX $1.26
- Average True Range (ATR)
- ATNF 0.08
- BDRX 0.12
- MACD
- ATNF -0.01
- BDRX 0.01
- Stochastic Oscillator
- ATNF 35.29
- BDRX 15.22
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.